Worth a read
http://www.investing.com/analysis/transgene:-staying-in-control-of-its-future-204796
The last paragraph in above article
The main catalyst after the fundraising is the potential in-licensing of TG4010 by Novartis, which we expect it to do following the positive data from the TIME trial.
Heres hoping they are on the money
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
-0.001(3.23%) |
Mkt cap ! $51.55M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.1¢ | 3.0¢ | $12.11K | 395.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 992444 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 1730595 | 5 |
View Market Depth
| Last trade - 15.59pm 11/07/2025 (20 minute delay) ? |
| VHL (ASX) Chart |